Faster diagnoses and better therapies with personalized active ingredients make a decisive contribution to the successful treatment of patients. As part of the Personalized Medicine Focus day, the latest developments in this field will be analyzed from a variety of perspectives.
With the help of differential and personalized diagnoses it is increasingly possible to develop individual, highly effective therapies. And yet Germany is far behind compared to Denmark or even Estonia. What do other countries do better?
And digitalisation is also playing an increasingly important role in this environment. Digital transformation places high demands on data security and handling. And yet experts agree that this development will bring about a groundbreaking change in the research, development, approval and financing of drugs.
The latest developments in this field will be examined from various perspectives at the personalized medicine theme day on 3 April. Experts from biotech, pharmaceutical and IT diagnostics companies, associations and clusters will discuss the current status and future orientation of personalized medicine.
